Amrutanjan Health Care Limited Asset Resilience Ratio
Amrutanjan Health Care Limited asset resilience ratio. Amrutanjan Health Care Limited (AMRUTANJAN) has an Asset Resilience Ratio of 61.39% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Amrutanjan Health Care Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Amrutanjan Health Care Limited (2006–2025)
Asset resilience ratio of Amrutanjan Health Care Limited from 2006 to 2025. This chart shows how Amrutanjan Health Care Limited's Asset Resilience Ratio has changed over time. Read Amrutanjan Health Care Limited (AMRUTANJAN) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Amrutanjan Health Care Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Amrutanjan Health Care Limited.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs631.16 Million | 14.6% |
| Short-term Investments | Rs2.02 Billion | 46.79% |
| Total Liquid Assets | Rs2.65 Billion | 61.39% |
Asset Resilience Insights
- Very High Liquidity: Amrutanjan Health Care Limited maintains exceptional liquid asset reserves at 61.39% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Amrutanjan Health Care Limited Industry Peers by Asset Resilience Ratio
Compare Amrutanjan Health Care Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Amrutanjan Health Care Limited Asset Resilience Ratio by Year (2006–2025)
Amrutanjan Health Care Limited asset resilience ratio by year from 2006 to 2025. The table below shows the annual Asset Resilience Ratio data for Amrutanjan Health Care Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 43.93% | Rs1.85 Billion ≈ $20.02 Million |
Rs4.21 Billion ≈ $45.57 Million |
-11.53pp |
| 2024-03-31 | 55.46% | Rs2.03 Billion ≈ $22.00 Million |
Rs3.67 Billion ≈ $39.68 Million |
+18.67pp |
| 2023-03-31 | 36.79% | Rs1.33 Billion ≈ $14.41 Million |
Rs3.62 Billion ≈ $39.16 Million |
+3.18pp |
| 2022-03-31 | 33.61% | Rs1.18 Billion ≈ $12.72 Million |
Rs3.50 Billion ≈ $37.84 Million |
+17.34pp |
| 2021-03-31 | 16.28% | Rs446.38 Million ≈ $4.83 Million |
Rs2.74 Billion ≈ $29.66 Million |
-2.72pp |
| 2020-03-31 | 19.00% | Rs390.11 Million ≈ $4.22 Million |
Rs2.05 Billion ≈ $22.21 Million |
-14.96pp |
| 2019-03-31 | 33.95% | Rs637.04 Million ≈ $6.89 Million |
Rs1.88 Billion ≈ $20.29 Million |
-26.18pp |
| 2018-03-31 | 60.14% | Rs998.17 Million ≈ $10.79 Million |
Rs1.66 Billion ≈ $17.95 Million |
+55.48pp |
| 2017-03-31 | 4.66% | Rs75.82 Million ≈ $819.93K |
Rs1.63 Billion ≈ $17.60 Million |
+4.58pp |
| 2015-03-31 | 0.08% | Rs1.02 Million ≈ $10.98K |
Rs1.24 Billion ≈ $13.40 Million |
-0.01pp |
| 2014-03-31 | 0.09% | Rs1.06 Million ≈ $11.42K |
Rs1.20 Billion ≈ $13.01 Million |
+0.03pp |
| 2013-03-31 | 0.06% | Rs766.55K ≈ $8.29K |
Rs1.24 Billion ≈ $13.43 Million |
-2.44pp |
| 2012-03-31 | 2.50% | Rs35.93 Million ≈ $388.57K |
Rs1.43 Billion ≈ $15.52 Million |
+1.82pp |
| 2006-03-31 | 0.68% | Rs2.52 Million ≈ $27.27K |
Rs370.01 Million ≈ $4.00 Million |
-- |
About Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn co… Read more